Germline heterozygous BAP1 mutations are responsible for the BAP1-cancer syndrome, an autosomal dominant condition characterized by high susceptibility to developing cancers, particularly uveal melanoma, malignant mesothelioma, cutaneous melanomas, renal cell carcinoma, and cholangiocarcinoma [124]. This evidence concerns the gene BAP1 and renal cell carcinoma.